SS-31: 14mg
Mitochondrial functionDescription
Ss-31 (also known as elamipretide, bendavia, and forzinity) is a synthetic aromatic-cationic tetrapeptide engineered to concentrate at the inner mitochondrial membrane at levels approximately 1,000–5,000 times higher than surrounding cellular tissue. its mechanism is precise: ss-31 binds cardiolipin, a phospholipid found exclusively in the inner mitochondrial membrane that holds the electron transport chain machinery in place. as cardiolipin degrades with age and oxidative stress, the electron transport chain loosens, energy output drops, and reactive oxygen species (ros) production spikes. ss-31 stabilizes cardiolipin, tightening respiratory complexes i, iii, and iv, reducing ros production, and restoring efficient atp generation. in aged mice, a single ss-31 injection restored in vivo mitochondrial energetics to young-mouse levels within one hour. ss-31 (as elamipretide/forzinity) received fda accelerated approval in september 2025 for barth syndrome, a rare genetic disorder defined by defective cardiolipin remodeling — making it the first mitochondria-targeted therapeutic approved in the united states. for research purposes in non-barth applications, ss-31 remains investigational. for research and educational purposes only.
Specifications
| Amount in Vial | 14mg |
|---|---|
| BAC Water | 1.2ml |
| Amount per Unit | 0.116mg per unit |
| Recommended Dose | 4.67mg (40 units) |
| Frequency | 7 bottle cycle 1x per day for 21 days 2 to 3x per year |
| Injection Type | Subcutaneous |
| Timing | Best To Use Before Running A MOTS-C Cycle |
Dose Calculator
Based on 0.116mg per unit (100-unit insulin syringe)
Quick Reference
Reconstitution
Vial size: 14mg
Add BAC water: 1.2ml
Concentration: 0.116mg per unit
For research and educational use only.
This page provides research dosing information only. Not intended as medical advice. Consult a qualified professional before any use.